文献速递血栓与止血白血病

造血转录因子突变:遗传性血小板缺陷的重要参与者

Hematopoietic transcription factor mutations: important players in inherited platelet defects.
PubMed 文献 · Blood · 2017-04-17

综述指出,多数遗传性血小板缺陷患者的分子遗传机制未知,越来越多证据显示造血转录因子突变是血小板生成、形态和功能缺陷的重要病因。涉及RUNX1、FLI1、GATA1、GFI1B、ETV6、EVI1和HOXA11等转录因子,突变通过组合方式调控多个基因表达,导致血小板减少和功能障碍,部分与血液恶性肿瘤易感性相关。

要点

  • 造血转录因子突变是遗传性血小板缺陷的重要病因,影响巨核细胞生物学及血小板生成与功能。
  • 涉及RUNX1、FLI1、GATA1、GFI1B、ETV6、EVI1和HOXA11等转录因子,以组合方式调控谱系特异性基因表达。
  • 部分转录因子突变与血液恶性肿瘤易感性相关,其变异频率可能高于一般认识。

核心结论

  • 造血转录因子突变是遗传性血小板缺陷的重要病因,可导致血小板减少和功能障碍,部分与血液恶性肿瘤易感性相关。

研究设计与样本

  • 综述,聚焦造血转录因子改变在遗传性血小板缺陷病理生物学中的作用。

主要发现

  • 多数遗传性血小板缺陷患者的分子和遗传机制未知。
  • 涉及血小板功能与数量受损的造血转录因子包括RUNX1、FLI1、GATA1、GFI1B、ETV6、EVI1和HOXA11。
  • 这些转录因子以组合方式结合启动子区序列特异性DNA,作为激活子或抑制子调控谱系特异性基因表达。
  • 转录因子突变通过同时改变多个基因表达产生下游连锁效应,影响巨核细胞生物学、血小板生成和功能。
  • 部分转录因子突变与血液恶性肿瘤易感性相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transcription factors (TFs) are proteins that bind to specific DNA sequences and regulate expression of genes. The molecular and genetic mechanisms in most patients with inherited platelet defects are unknown. There is now increasing evidence that mutations in hematopoietic TFs are an important underlying cause for defects in platelet production, morphology, and function. The hematopoietic TFs implicated in patients with impaired platelet function and number include runt-related transcription factor 1, Fli-1 proto-oncogene, E-twenty-six (ETS) transcription factor (friend leukemia integration 1), GATA-binding protein 1, growth factor independent 1B transcriptional repressor, ETS variant 6, ecotropic viral integration site 1, and homeobox A11. These TFs act in a combinatorial manner to bind sequence-specific DNA within promoter regions to regulate lineage-specific gene expression, either as activators or repressors. TF mutations induce rippling downstream effects by simultaneously altering the expression of multiple genes. Mutations involving these TFs affect diverse aspects of megakaryocyte biology, and platelet production and function, culminating in thrombocytopenia and platelet dysfunction. Some are associated with predisposition to hematologic malignancies. These TF variants may occur more frequently in patients with inherited platelet defects than generally appreciated. This review focuses on alterations in hematopoietic TFs in the pathobiology of inherited platelet defects.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Songdej N, Rao AK. Hematopoietic transcription factor mutations: important players in inherited platelet defects. Blood. 2017. PMID: 28416505. doi:10.1182/blood-2016-11-709881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。